Review

January 22, 2025


Unveiling the intratumor microbiome in liver cancer: Current insights and prospective applications
Xindi Ke, Shangze Jiang, Qiaoxin Wei, et al.
Clin Mol Hepatol. 2025;31(3):685-705.

Review

February 5, 2025


Deciphering adenosine signaling in hepatocellular carcinoma: Pathways, prognostic models, and therapeutic implications
Huihai Yang, Martina Mang Leng Lei, Longfei Xie, et al.
Clin Mol Hepatol. 2025;31(3):706-729.

Review

March 26, 2025


Tracking the trajectory of kidney dysfunction in cirrhosis: the acute kidney injury: chronic kidney disease spectrum
Vishnu Girish, Rakhi Maiwall
Clin Mol Hepatol. 2025;31(3):730-752.

Review

April 2, 2025


Emerging therapies and real-world application of metabolic dysfunction-associated steatotic liver disease treatment
Hee Yeon Kim, Mary E. Rinella
Clin Mol Hepatol. 2025;31(3):753-770.

Review

April 16, 2025


Role of amino acids in the regulation of hepatic gluconeogenesis and lipogenesis in metabolic dysfunctionassociated steatotic liver disease
Eiji Kakazu, Masaaki Mino, Tatsuya Kanto
Clin Mol Hepatol. 2025;31(3):771-795.

Original Article

January 6, 2025


High Steatosis-Associated Fibrosis Estimator scores predict hepatocellular carcinoma in viral and non-viral hepatitis and metabolic dysfunction-associated steatotic liver disease
Tung-Hung Su, Sheng-Shun Yang, Mei-Hsuan Lee, et al.
Clin Mol Hepatol. 2025;31(3):796-809.

Original Article

January 17, 2025


Switching to besifovir in patients with chronic hepatitis B receiving tenofovir disoproxil fumarate: A randomized trial
Hyung Joon Yim, Yeon Seok Seo, Ji Hoon Kim, et al.
Clin Mol Hepatol. 2025;31(3):810-822.

Original Article

January 22, 2025


Modulation of phosphatase of regenerating liver-1 within placental mesenchymal stem cells instigates the transition between epithelial-to-mesenchymal transition and mesenchymal-to-epithelial transition subsequent to hepatic fibrosis
Jae Yeon Kim, Hyeri Park, Soo Young Park, et al.
Clin Mol Hepatol. 2025;31(3):823-840.

Original Article

February 5, 2025


Glutamate dehydrogenase 1-dependent α-ketoglutarate promotes hepatitis B virus transcription by modulating histone methylations on the covalently closed circular DNA minichromosome
Sheng-Tao Cheng, Wei-Xian Chen, Hai-Jun Deng, et al.
Clin Mol Hepatol. 2025;31(3):841-865.

Original Article

February 5, 2025


Baveno VI-SSM stratifies the risk of portal hypertensionrelated events in patients with HBV-related cirrhosis
Haiyu Wang, Weihao Liang, Ling Zhou, et al.
Clin Mol Hepatol. 2025;31(3):866-880.

Original Article

February 5, 2025


Fibrosis-4plus score: a novel machine learning-based tool for screening high-risk varices in compensated cirrhosis (CHESS2004): an international multicenter study
Bingtian Dong, Ruiling He, Shenghong Ju, et al.
Clin Mol Hepatol. 2025;31(3):881-898.

Original Article

February 5, 2025


Direct-acting antiviral therapy for patients with hepatitis C virus-related hepatocellular carcinoma: A nationwide cohort study
Shou-Wu Lee, Sheng-Shun Yang, Pei-Chien Tsai, et al.
Clin Mol Hepatol. 2025;31(3):899-913.

Original Article

February 6, 2025


GULP1 as a novel diagnostic and predictive biomarker in hepatocellular carcinoma
Hyung Seok Kim, Jung Hwan Yoon, Ji Yi Choi, et al.
Clin Mol Hepatol. 2025;31(3):914-934.

Original Article

February 10, 2025


Radiogenomics of intrahepatic cholangiocarcinoma predicts immunochemotherapy response and identifies therapeutic target
Gu-Wei Ji, Zheng-Gang Xu, Shuo-Chen Liu, et al.
Clin Mol Hepatol. 2025;31(3):935-959.

Original Article

March 4, 2025


CD36 promotes iron accumulation and dysfunction in CD8+ T cells via the p38-CEBPB-TfR1 axis in earlystage hepatocellular carcinoma
Yifei Qin, Fei Huo, Zhuan Feng, et al.
Clin Mol Hepatol. 2025;31(3):960-980.

Original Article

March 11, 2025


Molecular classification of hepatocellular carcinoma based on zoned metabolic feature and oncogenic signaling pathway
Tomoko Aoki, Naoshi Nishida, Yutaka Kurebayashi, et al.
Clin Mol Hepatol. 2025;31(3):981-1002.

Original Article

March 17, 2025


Impacts of metabolic syndrome diseases on long-term outcomes of chronic hepatitis B patients treated with nucleos(t)ide analogues
Rui Huang, Dae Won Jun, Hidenori Toyoda, et al.
Clin Mol Hepatol. 2025;31(3):1003-1017.

Original Article

April 4, 2025


Risk stratification by noninvasive tests in patients with metabolic dysfunction-associated steatotic liver disease
Hye Won Lee, Jae Seung Lee, Mi Na Kim, et al.
Clin Mol Hepatol. 2025;31(3):1018-1031.

Original Article

April 11, 2025


MET promotes hepatocellular carcinoma development through the promotion of TRIB3-mediated FOXO1 degradation
Tiantian Wang, Dean Rao, Chenan Fu, et al.
Clin Mol Hepatol. 2025;31(3):1032-1057.

Original Article

April 11, 2025


Sex disparities in alcohol-associated liver disease and subtype differences in alcohol-attributable cancers in the United States
Pojsakorn Danpanichkul, Yanfang Pang, Tanuj Mahendru, et al.
Clin Mol Hepatol. 2025;31(3):1058-1070.

Original Article

April 21, 2025


HTD1801 demonstrates promising potential for histologic improvements in metabolic dysfunction-associated steatohepatitis in both a preclinical and phase 2 study
Vincent Wai-Sun Wong, Guy W. Neff, Adrian M. Di Bisceglie, et al.
Clin Mol Hepatol. 2025;31(3):1071-1083.

Original Article

April 23, 2025


Glucagon-like peptide 1 receptor agonist and reduced liver and non-liver complications in adults with type 2 diabetes and metabolic dysfunction-associated steatotic liver disease: a target trial emulation study
Xianhua Mao, Xinrong Zhang, Rongtao Lai, et al.
Clin Mol Hepatol. 2025;31(3):1084-1099.


This archive contains links to the full-text of all issues of Clin Mol Hepatol.

Current issue

Volume 31(3); July

All issues

Vol. 31
2025

v.31(1)
Jan 2025


v.31(Suppl)
Feb 2025


v.31(2)
Apr 2025


v.31(3)
Jul 2025

Vol. 30
2024

v.30(1)
Jan 2024


v.30(2)
Apr 2024


v.30(3)
Jul 2024


v.30(Suppl)
Sep 2024


v.30(4)
Oct 2024

Vol. 29
2023

v.29(1)
Jan 2023


v.29(Suppl)
Feb 2023


v.29(2)
Apr 2023


v.29(3)
Jul 2023


v.29(4)
Oct 2023

Vol. 28
2022

v.28(1)
Jan 2022


v.28(2)
Apr 2022


v.28(3)
Jul 2022


v.28(4)
Oct 2022

Vol. 27
2021

v.27(1)
Jan 2021


v.27(2)
Apr 2021


v.27(3)
Jul 2021


v.27(4)
Oct 2021

Vol. 26
2020

v.26(1)
Jan 2020


v.26(2)
Apr 2020


v.26(3)
Jul 2020


v.26(4)
Oct 2020

Vol. 25
2019

v.25(1)
Mar 2019

v.25(2)
Jun 2019

v.25(3)
Sep 2019
v.25(4)
Dec 2019
Vol. 24
2018

v.24(1)
Mar 2018

v.24(2)
Jun 2018

v.24(3)
Sep 2018

v.24(4)
Dec 2018
Vol. 23
2017

v.23(1)
Mar 2017

v.23(2)
Jun 2017

v.23(3)
Sep 2017

v.23(4)
Dec 2017
Vol. 22
2016

v.22(1)
Mar 2016

v.22(2)
Jun 2016

v.22(3)
Sep 2016

v.22(4)
Dec 2016
Vol. 21
2015

v.21(1)
Mar 2015

v.21(2)
Jun 2015

v.21(3)
Sep 2015

v.21(4)
Dec 2015
Vol. 20
2014

v.20(1)
Mar 2014

v.20(2)
Jun 2014

v.20(3)
Sep 2014

v.20(4)
Dec 2014
Vol. 19
2013

v.19(1)
Mar 2013

v.19(2)
Jun 2013

v.19(3)
Sep 2013

v.19(4)
Dec 2013
The Korean Journal of Hepatology1995 (Vol.1 No.1) to 2012 (Vol.18 No.1)
Vol. 18
2012

v.18(1)
Mar 2012

v.18(2)
Jun 2012

v.18(3)
Sep 2012

v.18(4)
Dec 2012
Vol. 17
2011
v.17(1)
Mar 2011
v.17(2)
Jun 2011
v.17(3)
Sep 2011
v.17(4)
Dec 2011
Vol. 16
2010
v.16(1)
Mar 2010
v.16(2)
Jun 2010
v.16(3)
Sep 2010
v.16(4)
Dec 2010
Vol. 15
2009
v.15(1)
Mar 2009
v.15(2)
Jun 2009
v.15(3)
Sep 2009
v.15(4)
Dec 2009
v.15(60)
Dec 2009
Vol. 14
2008
v.14(1)
Mar 2008
v.14(2)
Jun 2008
v.14(3)
Sep 2008
v.14(4)
Dec 2008
Vol. 13
2007
v.13(1)
Mar 2007
v.13(2)
Jun 2007
v.13(3)
Sep 2007
v.13(4)
Dec 2007
Vol. 12
2006
v.12(1)
Mar 2006
v.12(2)
Jun 2006
v.12(3)
Sep 2006
v.12(4)
Dec 2006
Vol. 11
2005
v.11(1)
Mar 2005
v.11(2)
Jun 2005
v.11(3)
Sep 2005
v.11(4)
Dec 2005
Vol. 10
2004
v.10(1)
Mar 2004
v.10(2)
Jun 2004
v.10(3)
Sep 2004
v.10(4)
Dec 2004
Vol. 9
2003
v.9(1)
Mar 2003
v.9(2)
Jun 2003
v.9(3)
Sep 2003
v.9(4)
Dec 2003
Vol. 8
2002
v.8(1)
Mar 2002
v.8(2)
Jun 2002
v.8(3)
Sep 2002
v.8(4)
Dec 2002
Vol. 7
2001
v.7(1)
Mar 2001
v.7(2)
Jun 2001
v.7(3)
Sep 2001
v.7(4)
Dec 2001
Vol. 6
2000
v.6(1)
Mar 2000
v.6(2)
Jun 2000
v.6(3)
Sep 2000
v.6(4)
Dec 2000
Vol. 5
1999
v.5(1)
Mar 1999
v.5(2)
Jun 1999
v.5(3)
Sep 1999
v.5(4)
Dec 1999
Vol. 4
1998
v.4(1)
Mar 1998
v.4(2)
Jun 1998
v.4(3)
Sep 1998
v.4(4)
Dec 1998
Vol. 3
1997
v.3(1)
Mar 1997
v.3(2)
Jun 1997
v.3(3)
Sep 1997
v.3(4)
Dec 1997
Vol. 2
1996
v.2(1)
Jun 1996
v.2(2)
Dec 1996
Vol. 1
1995
v.1(1)
Jun 1995

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X

ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS
FOLLOW US
Twitter
Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: cmh_journal@ijpnc.com
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 3752
TOTAL : 2925944
Close layer